Title: Compositions for RNA Interference and Methods of Use Thereof
Patent Number: 8,729,036
Filed: Aug. 7, 2003
Lead Inventor: Phillip Zamore, University of Massachusetts
Title: Method and Medicament for Inhibiting the Expression of a Given Gene
Patent Number: 8,729,037
Filed: Oct. 31, 2007
Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals
Title: Downregulation of the Gene Expression by Means of Nucleic Acid-loaded Virus-like Particles
Patent Number: 8,729,038
Filed: Sept. 12, 2008
Lead Inventor: Jens Gruber, University of Amsterdam
Title: Compositions and Methods for Treating Hepatic Neoplasia
Patent Number: 8,729,041
Filed: Dec. 2, 2009
Lead Inventor: Joshua Mendell, Johns Hopkins University
Title: Supercoiled Minivectors for Gene Therapy Applications
Patent Number: 8,729,044
Filed: Oct. 15, 2010
Lead Inventor: Lynn Zechiedrich, Baylor College of Medicine
Title: Compositions and Methods for Short Interfering Nucleic Acid Inhibition of Nav1.8
Patent Number: 8,729,045
Filed: Oct. 16, 2012
Lead Inventor: Sameer Goregaoker, Merck
Title: Antisense Oligonucleotides for Inhibition of microRNA-21
Patent Number: 8,729,250
Filed: March 8, 2012
Lead Inventor: Joacim Elmen, Santaris Pharma
Title: Gene Silencing
Patent Number: 8,729,339
Filed: Dec. 18, 2007
Inventor: Milo Aukerman, DuPont